Bottom line
Is FXSCX a good fund? The bottom line
FXSCX is an index small-cap mutual fund from Fidelity.
It charges 0% — about $0 a year on every $10,000 invested, cheaper than 99% of small-cap funds we track.
With $18.1 million in net assets and 892 holdings, its largest position is Hut 8 Corp (0.5%) and the top 10 make up 3.9% of the portfolio.
What stands out
- Low cost: cheaper than 99% of small-cap peers
- Broadly diversified (892 holdings)
What to watch
- Small fund ($18.1 million) — small funds are likelier to close
- High turnover (115% a year) can mean more taxable distributions
Updated Nov 19, 2026
What FXSCX invests in
Fidelity Flex Small Cap Focused Index Fund seeks to provide investment results that correspond to the total return of stocks of small-capitalization U.S. companies.
Normally investing at least 80% of assets in securities of small-capitalization companies included in the Fidelity U.S. Small Cap Focused IndexSM. The Fidelity U.S. Small Cap Focused Index SM is designed to reflect the performance of stocks of small-capitalization companies. Small-capitalization stocks are considered to be stocks whose market capitalization is similar to the market capitalization of companies in the Russell 2000 Index or the S&P SmallCap 600 Index. The Fidelity U.S. Small Cap Focused Index SM was created by Fidelity Product Services LLC (FPS) using a rules-based proprietary index methodology that includes all U.S. stocks meeting certain market capitalization, liquidity and investability requirements. Derivative instruments that provide investment exposure to the investments above or exposure to one or more market risk factors associated with such investments are…
From the fund's prospectus (filed Jun 24, 2026).
What FXSCX costs
On a $10,000 investment, FXSCX's 0% expense ratio costs about $0 a year. The median small-cap fund charges 0.99%.
FXSCX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Hut 8 Corp | 0.50% |
| 2 | Sanmina Corp | 0.43% |
| 3 | Glaukos Corp | 0.42% |
| 4 | Brightspring Health Services Inc | 0.40% |
| 5 | Axsome Therapeutics Inc | 0.40% |
| 6 | Spyre Therapeutics Inc | 0.37% |
| 7 | Stonex Group Inc | 0.36% |
| 8 | Apogee Therapeutics Inc | 0.34% |
| 9 | Avnet Inc | 0.34% |
| 10 | Sharkninja Inc | 0.33% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 3.9% of the fund. See all top 25 holdings and asset mix →